These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 3044708)

  • 21. Lyodura use and the risk of iatrogenic Creutzfeldt-Jakob disease in Australia.
    Brooke FJ; Boyd A; Klug GM; Masters CL; Collins SJ
    Med J Aust; 2004 Feb; 180(4):177-81. PubMed ID: 14960140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iatrogenic Creutzfeldt-Jakob disease subsequent to dural graft: persisting risk after 1987.
    Boutoleau C; Guillon B; Martinez F; Vercelletto M; Faure A; Fève JR
    Eur J Neurol; 2003 Sep; 10(5):521-3. PubMed ID: 12940833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iatrogenic Creutzfeldt-Jakob disease: the waning of an era.
    Brown P; Brandel JP; Preece M; Sato T
    Neurology; 2006 Aug; 67(3):389-93. PubMed ID: 16855204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Epidemiological surveillance of Creutzfeldt-Jakob in France].
    Brandel JP; Salomon D; Capek I; Vaillant V; Alpérovitch A
    Rev Neurol (Paris); 2009; 165(8-9):684-93. PubMed ID: 19467685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Creutzfeldt-Jakob disease via dural and corneal transplants.
    Lang CJ; Heckmann JG; Neundörfer B
    J Neurol Sci; 1998 Oct; 160(2):128-39. PubMed ID: 9849795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease.
    Collinge J; Palmer MS; Dryden AJ
    Lancet; 1991 Jun; 337(8755):1441-2. PubMed ID: 1675319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human growth hormone-related iatrogenic Creutzfeldt-Jakob disease: search for a genetic susceptibility by analysis of the PRNP coding region.
    Jaegly A; Boussin F; Deslys JP; Dormont D
    Genomics; 1995 May; 27(2):382-3. PubMed ID: 7558015
    [No Abstract]   [Full Text] [Related]  

  • 28. Insight into the frequent occurrence of dura mater graft-associated Creutzfeldt-Jakob disease in Japan.
    Hamaguchi T; Sakai K; Noguchi-Shinohara M; Nozaki I; Takumi I; Sanjo N; Sadakane A; Nakamura Y; Kitamoto T; Saito N; Mizusawa H; Yamada M
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1171-5. PubMed ID: 23595947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevention of prion disease transmission].
    Kishida H; Kuroiwa Y
    Nihon Rinsho; 2007 Aug; 65(8):1454-9. PubMed ID: 17695283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts -- Japan, January 1979-May 1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Nov; 46(45):1066-9. PubMed ID: 9385874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iatrogenic Creutzfeldt-Jakob disease.
    Rappaport EB
    Neurology; 1987 Sep; 37(9):1520-2. PubMed ID: 3306455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pituitary growth hormone and Creutzfeldt-Jakob disease.
    Norrby E
    Acta Paediatr Scand Suppl; 1986; 325():116-24. PubMed ID: 3296633
    [No Abstract]   [Full Text] [Related]  

  • 33. Creutzfeldt-Jakob disease and lyophilised dura mater grafts: report of two cases.
    Esmonde T; Lueck CJ; Symon L; Duchen LW; Will RG
    J Neurol Neurosurg Psychiatry; 1993 Sep; 56(9):999-1000. PubMed ID: 8410042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Creutzfeldt-Jakob disease following pituitary-derived human growth hormone therapy: a new American case.
    Marzewski DJ; Towfighi J; Harrington MG; Merril CR; Brown P
    Neurology; 1988 Jul; 38(7):1131-3. PubMed ID: 3290703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathologic characteristics of five autopsied cases of dura mater-associated Creutzfeldt-Jakob disease.
    Iwasaki Y; Mimuro M; Yoshida M; Hashizume Y; Kitamoto T; Sobue G
    Neuropathology; 2008 Feb; 28(1):51-61. PubMed ID: 18181835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Iatrogenic Creutzfeldt-Jakob disease].
    Satoh K; Shirabe S; Katamine S; Muramoto T; Kitamoto T
    Nihon Rinsho; 2004 Jan; 62 Suppl():248-51. PubMed ID: 15011359
    [No Abstract]   [Full Text] [Related]  

  • 37. Creutzfeldt-Jakob disease in a patient with a lyophilized dura mater graft.
    Liscić RM; Brinar V; Miklić P; Barsić B; Himbele J
    Acta Med Croatica; 1999; 53(2):93-6. PubMed ID: 10705627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iatrogenic Creutzfeldt-Jakob disease in three growth hormone recipients: a neuropathological study.
    Billette de Villemeur T; Gelot A; Deslys JP; Dormont D; Duyckaerts C; Jardin L; Denni J; Robain O
    Neuropathol Appl Neurobiol; 1994 Apr; 20(2):111-7. PubMed ID: 8072642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human prion diseases: surgical lessons learned from iatrogenic prion transmission.
    Bonda DJ; Manjila S; Mehndiratta P; Khan F; Miller BR; Onwuzulike K; Puoti G; Cohen ML; Schonberger LB; Cali I
    Neurosurg Focus; 2016 Jul; 41(1):E10. PubMed ID: 27364252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oh, dura dear! What can the mater be?
    Weber KT
    Cardiovasc Res; 1998 Apr; 38(1):3-5. PubMed ID: 9683903
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.